Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 14 | 2023 | 235 | 4.330 |
Why?
|
| Stroke Volume | 2 | 2020 | 89 | 1.280 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 101 | 1.230 |
Why?
|
| Patient Readmission | 2 | 2018 | 73 | 1.120 |
Why?
|
| Myocarditis | 2 | 2020 | 20 | 1.010 |
Why?
|
| Ventricular Function, Left | 2 | 2020 | 96 | 0.770 |
Why?
|
| Telemetry | 2 | 2010 | 14 | 0.710 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 225 | 0.710 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 85 | 0.690 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2018 | 52 | 0.630 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 485 | 0.610 |
Why?
|
| Cocaine-Related Disorders | 1 | 2018 | 85 | 0.600 |
Why?
|
| Digoxin | 1 | 2017 | 6 | 0.600 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 12 | 0.600 |
Why?
|
| Dyslipidemias | 1 | 2016 | 43 | 0.540 |
Why?
|
| Medicaid | 1 | 2017 | 109 | 0.540 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 77 | 0.530 |
Why?
|
| Humans | 37 | 2024 | 37093 | 0.520 |
Why?
|
| Quality of Life | 1 | 2020 | 481 | 0.520 |
Why?
|
| Middle Aged | 22 | 2024 | 10129 | 0.520 |
Why?
|
| Atherosclerosis | 1 | 2016 | 134 | 0.500 |
Why?
|
| Risk Factors | 10 | 2024 | 3562 | 0.500 |
Why?
|
| Cardiovascular Diseases | 3 | 2024 | 664 | 0.460 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 494 | 0.430 |
Why?
|
| Hypertension | 6 | 2024 | 796 | 0.410 |
Why?
|
| Electrocardiography | 3 | 2011 | 156 | 0.400 |
Why?
|
| Thrombosis | 2 | 2003 | 63 | 0.390 |
Why?
|
| Aortic Coarctation | 1 | 2011 | 2 | 0.390 |
Why?
|
| Aged | 15 | 2024 | 6741 | 0.380 |
Why?
|
| Hospitalization | 4 | 2017 | 388 | 0.380 |
Why?
|
| Patient Admission | 1 | 2010 | 41 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 5 | 2021 | 191 | 0.360 |
Why?
|
| Heart Diseases | 2 | 2009 | 104 | 0.350 |
Why?
|
| Coronary Angiography | 3 | 2011 | 90 | 0.350 |
Why?
|
| United States | 6 | 2023 | 4223 | 0.340 |
Why?
|
| Adult | 14 | 2024 | 11712 | 0.340 |
Why?
|
| Male | 19 | 2020 | 20025 | 0.340 |
Why?
|
| Female | 20 | 2020 | 20969 | 0.330 |
Why?
|
| Time Factors | 3 | 2018 | 1742 | 0.320 |
Why?
|
| Incidence | 3 | 2022 | 922 | 0.300 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 7 | 0.290 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2026 | 0.290 |
Why?
|
| Coronary Vessels | 2 | 2011 | 85 | 0.280 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 225 | 0.280 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2003 | 20 | 0.270 |
Why?
|
| Treatment Outcome | 4 | 2018 | 1369 | 0.270 |
Why?
|
| Risk Assessment | 4 | 2024 | 753 | 0.260 |
Why?
|
| Heart Block | 1 | 2004 | 2 | 0.250 |
Why?
|
| Cardiac Tamponade | 1 | 2004 | 4 | 0.250 |
Why?
|
| Shock, Cardiogenic | 1 | 2004 | 10 | 0.250 |
Why?
|
| American Heart Association | 1 | 2023 | 21 | 0.240 |
Why?
|
| Health Facilities | 1 | 2023 | 27 | 0.230 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 155 | 0.220 |
Why?
|
| Prognosis | 3 | 2020 | 739 | 0.220 |
Why?
|
| Troponin T | 1 | 2022 | 9 | 0.220 |
Why?
|
| Troponin I | 1 | 2022 | 18 | 0.210 |
Why?
|
| Pulmonary Embolism | 1 | 2003 | 32 | 0.210 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2022 | 21 | 0.210 |
Why?
|
| Protein S Deficiency | 1 | 2001 | 1 | 0.200 |
Why?
|
| Protein C Deficiency | 1 | 2001 | 1 | 0.200 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 610 | 0.200 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2021 | 13 | 0.190 |
Why?
|
| Georgia | 4 | 2021 | 174 | 0.190 |
Why?
|
| Aortic Diseases | 1 | 2001 | 27 | 0.190 |
Why?
|
| Disease Management | 1 | 2021 | 61 | 0.190 |
Why?
|
| Stroke | 1 | 2024 | 286 | 0.180 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 441 | 0.160 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 583 | 0.160 |
Why?
|
| Arteriosclerosis | 1 | 1998 | 36 | 0.160 |
Why?
|
| Prevalence | 3 | 2016 | 1455 | 0.160 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 45 | 0.160 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 560 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 140 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 217 | 0.150 |
Why?
|
| Drug Utilization Review | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cause of Death | 1 | 2018 | 156 | 0.150 |
Why?
|
| Propensity Score | 1 | 2017 | 38 | 0.150 |
Why?
|
| Academic Medical Centers | 2 | 2023 | 60 | 0.140 |
Why?
|
| Age Factors | 2 | 2016 | 1033 | 0.140 |
Why?
|
| Young Adult | 2 | 2017 | 4268 | 0.140 |
Why?
|
| Odds Ratio | 2 | 2016 | 534 | 0.140 |
Why?
|
| Comorbidity | 2 | 2016 | 623 | 0.130 |
Why?
|
| Medicare | 1 | 2017 | 195 | 0.130 |
Why?
|
| Urban Population | 2 | 2010 | 333 | 0.130 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 242 | 0.130 |
Why?
|
| Logistic Models | 2 | 2016 | 923 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 208 | 0.120 |
Why?
|
| Disease Progression | 1 | 2017 | 601 | 0.120 |
Why?
|
| New York City | 2 | 2006 | 220 | 0.120 |
Why?
|
| Blood Pressure | 4 | 2011 | 646 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 2379 | 0.110 |
Why?
|
| Heart Failure, Systolic | 1 | 2011 | 4 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2019 | 1378 | 0.100 |
Why?
|
| Aortography | 1 | 2011 | 10 | 0.100 |
Why?
|
| Health Policy | 2 | 2023 | 165 | 0.100 |
Why?
|
| Exercise Therapy | 1 | 2011 | 69 | 0.100 |
Why?
|
| Anticoagulants | 2 | 2003 | 102 | 0.100 |
Why?
|
| Organizational Policy | 1 | 2010 | 22 | 0.090 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 12 | 0.090 |
Why?
|
| Length of Stay | 1 | 2010 | 185 | 0.080 |
Why?
|
| Health Promotion | 2 | 2024 | 653 | 0.080 |
Why?
|
| Community Networks | 2 | 2006 | 108 | 0.080 |
Why?
|
| Health Literacy | 1 | 2010 | 105 | 0.080 |
Why?
|
| Echocardiography | 2 | 2011 | 144 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 144 | 0.080 |
Why?
|
| Patient Selection | 1 | 2009 | 164 | 0.080 |
Why?
|
| Exercise | 1 | 2013 | 613 | 0.080 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 17 | 0.070 |
Why?
|
| Defibrillators, Implantable | 1 | 2007 | 35 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2006 | 66 | 0.070 |
Why?
|
| Adolescent | 1 | 2017 | 5363 | 0.070 |
Why?
|
| Radionuclide Imaging | 1 | 2006 | 28 | 0.070 |
Why?
|
| Medical Audit | 1 | 2006 | 25 | 0.070 |
Why?
|
| Physical Examination | 1 | 2006 | 43 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 204 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2013 | 325 | 0.060 |
Why?
|
| Health Status Disparities | 1 | 2010 | 642 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 128 | 0.060 |
Why?
|
| Medical Assistance | 1 | 2023 | 5 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 41 | 0.060 |
Why?
|
| Writing | 1 | 2023 | 37 | 0.060 |
Why?
|
| Hirudin Therapy | 1 | 2003 | 1 | 0.060 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 7 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2005 | 233 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 219 | 0.050 |
Why?
|
| Heart Atria | 1 | 2003 | 26 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 198 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2023 | 169 | 0.050 |
Why?
|
| Mentors | 1 | 2023 | 127 | 0.050 |
Why?
|
| Heart | 1 | 2024 | 180 | 0.050 |
Why?
|
| Warfarin | 1 | 2003 | 64 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 276 | 0.050 |
Why?
|
| Registries | 2 | 2019 | 335 | 0.050 |
Why?
|
| Exercise Test | 1 | 2001 | 67 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2001 | 28 | 0.050 |
Why?
|
| Transportation | 1 | 2021 | 26 | 0.050 |
Why?
|
| Home Care Services | 1 | 2021 | 33 | 0.050 |
Why?
|
| Social Work | 1 | 2021 | 49 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2001 | 124 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2021 | 179 | 0.040 |
Why?
|
| Autopsy | 1 | 1998 | 43 | 0.040 |
Why?
|
| Health Education | 1 | 2021 | 338 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2721 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1067 | 0.040 |
Why?
|
| Acute Disease | 1 | 2016 | 147 | 0.030 |
Why?
|
| Chest Pain | 1 | 2011 | 37 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 75 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 484 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 318 | 0.020 |
Why?
|
| Social Support | 1 | 2010 | 394 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 25 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 104 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 54 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2005 | 27 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2005 | 149 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 67 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 225 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2005 | 215 | 0.020 |
Why?
|
| Alleles | 1 | 2005 | 321 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 138 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 448 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 237 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2005 | 294 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 628 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 767 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 596 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 974 | 0.010 |
Why?
|